Brief: Hls Therapeutics Announces Qtrly Net Loss $0.19 Per Common Share

HLS Therapeutics

16/05/2018 11:35

May 16 (Reuters) - HLS Therapeutics Inc  HLS.V :
    * HLS THERAPEUTICS ANNOUNCES Q1 2018 FINANCIAL RESULTS
    * CASH AND CASH EQUIVALENTS $53.8 MILLION AT END OF Q1
    * Q1 REVENUE $13.2 MILLION VERSUS $15.6 MILLION
    * QTRLY NET LOSS $0.19 PER COMMON SHARE

Source text for Eikon:  ID:nCNWjvdmMa 
Further company coverage:  HLS.V 

 (Reuters.Briefs@thomsonreuters.com)